Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

272 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Graphical and numerical diagnostic tools to assess suitability of multiple imputations and imputation models.
Bondarenko I, Raghunathan T. Bondarenko I, et al. Stat Med. 2016 Jul 30;35(17):3007-20. doi: 10.1002/sim.6926. Epub 2016 Mar 7. Stat Med. 2016. PMID: 26952693
This article develops and evaluates a set of graphical and numerical diagnostic tools for two practical purposes: (i) for an analyst to determine whether the imputations are reasonable under his/her model assumptions without actually knowing the imputation model assumption …
This article develops and evaluates a set of graphical and numerical diagnostic tools for two practical purposes: (i) for an analyst …
Propensity score-based diagnostics for categorical response regression models.
Boonstra PS, Bondarenko I, Park SK, Vokonas PS, Mukherjee B. Boonstra PS, et al. Stat Med. 2014 Feb 10;33(3):455-469. doi: 10.1002/sim.5940. Epub 2013 Aug 12. Stat Med. 2014. PMID: 23934948 Free PMC article.
We illustrate the methods with simulation studies and two data examples: (i) a case-control study of the association between cumulative lead exposure and Parkinson's disease in the Boston, Massachusetts, area and (ii) and a cohort study of biomarkers possibly associated wi …
We illustrate the methods with simulation studies and two data examples: (i) a case-control study of the association between cumulati …
Second Opinions From Medical Oncologists for Early-Stage Breast Cancer: Prevalence, Correlates, and Consequences.
Kurian AW, Friese CR, Bondarenko I, Jagsi R, Li Y, Hamilton AS, Ward KC, Katz SJ. Kurian AW, et al. JAMA Oncol. 2017 Mar 1;3(3):391-397. doi: 10.1001/jamaoncol.2016.5652. JAMA Oncol. 2017. PMID: 28033448 Free PMC article.
RESULTS: A total of 1901 patients with stage I to II breast cancer (mean [SD] age, 61.6 [11.0] years; 1071 [56.3%] non-Hispanic white) saw any medical oncologist. ...
RESULTS: A total of 1901 patients with stage I to II breast cancer (mean [SD] age, 61.6 [11.0] years; 1071 [56.3%] non-Hispanic white …
The influence of 21-gene recurrence score assay on chemotherapy use in a population-based sample of breast cancer patients.
Li Y, Kurian AW, Bondarenko I, Taylor JMG, Jagsi R, Ward KC, Hamilton AS, Katz SJ, Hofer TP. Li Y, et al. Breast Cancer Res Treat. 2017 Feb;161(3):587-595. doi: 10.1007/s10549-016-4086-3. Epub 2016 Dec 23. Breast Cancer Res Treat. 2017. PMID: 28012085 Free PMC article. Clinical Trial.
RESULTS: A half of the 1545 women eligible for testing (ER+ or PR+, HER2-, and stage I-II) received RS. We estimate that 30% (95% confidence interval (CI) 10-49%) of patients would have changed their treatment selections after RS assay, with 10% (CI 0-20%) being encouraged …
RESULTS: A half of the 1545 women eligible for testing (ER+ or PR+, HER2-, and stage I-II) received RS. We estimate that 30% (95% con …
It is not just menopause: symptom clustering in the Study of Women's Health Across the Nation.
Harlow SD, Karvonen-Gutierrez C, Elliott MR, Bondarenko I, Avis NE, Bromberger JT, Brooks MM, Miller JM, Reed BD. Harlow SD, et al. Womens Midlife Health. 2017;3:2. doi: 10.1186/s40695-017-0021-y. Epub 2017 Jul 27. Womens Midlife Health. 2017. PMID: 29326841 Free PMC article.
Chemotherapy decisions and patient experience with the recurrence score assay for early-stage breast cancer.
Friese CR, Li Y, Bondarenko I, Hofer TP, Ward KC, Hamilton AS, Deapen D, Kurian AW, Katz SJ. Friese CR, et al. Cancer. 2017 Jan 1;123(1):43-51. doi: 10.1002/cncr.30324. Epub 2016 Oct 24. Cancer. 2017. PMID: 27775837 Free PMC article.
RESULTS: There were 1527 patients with stage I/II, estrogen receptor/progesterone receptor-positive, human epidermal growth factor 2-negative disease: 778 received an RS (62.6% of patients with node-negative, favorable disease, 24.3% of patients with node-negative, unfavor …
RESULTS: There were 1527 patients with stage I/II, estrogen receptor/progesterone receptor-positive, human epidermal growth factor 2- …
Association of Attending Surgeon With Variation in the Receipt of Genetic Testing After Diagnosis of Breast Cancer.
Katz SJ, Bondarenko I, Ward KC, Hamilton AS, Morrow M, Kurian AW, Hofer TP. Katz SJ, et al. JAMA Surg. 2018 Oct 1;153(10):909-916. doi: 10.1001/jamasurg.2018.2001. JAMA Surg. 2018. PMID: 29971344 Free PMC article. Clinical Trial.
Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
Kurian AW, Ward KC, Hamilton AS, Deapen DM, Abrahamse P, Bondarenko I, Li Y, Hawley ST, Morrow M, Jagsi R, Katz SJ. Kurian AW, et al. JAMA Oncol. 2018 Aug 1;4(8):1066-1072. doi: 10.1001/jamaoncol.2018.0644. JAMA Oncol. 2018. PMID: 29801090 Free PMC article.
Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer.
Kurian AW, Bondarenko I, Jagsi R, Friese CR, McLeod MC, Hawley ST, Hamilton AS, Ward KC, Hofer TP, Katz SJ. Kurian AW, et al. J Natl Cancer Inst. 2018 May 1;110(5):493-500. doi: 10.1093/jnci/djx239. J Natl Cancer Inst. 2018. PMID: 29237009 Free PMC article.
RESULTS: The analytic sample was 2926 patients with stage I-II, estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. ...
RESULTS: The analytic sample was 2926 patients with stage I-II, estrogen receptor-positive, human epidermal growth factor receptor 2- …
272 results
Jump to page
Feedback